Retroviral, transgenic and conditional knock-in (KI) mouse models showed that expression of JAK2V617F is sufficient to recapitulate a MPN phenotype 11–14, indicating the central role of constitutive activation of the JAK2/STAT pathway in these pathologies. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.